Appendiceal Cancer

2017 ◽  
pp. 125-130
Author(s):  
Dongyou Liu
Keyword(s):  
Appendiceal Cancer

scholarly journals Nomograms predicting overall survival and cancer-specific survival for patients with appendiceal cancer after surgery

All Life ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 428-440
Author(s):  
Yuan Zhou ◽  
Dan Wang ◽  
Chongshun Liu ◽  
Tingyu Yan ◽  
Chenglong Li ◽  
...  
Keyword(s):  
Overall Survival ◽  
Appendiceal Cancer ◽  
Cancer Specific Survival

scholarly journals Laparoscopic ileocecal resection can be applied for appendiceal cancer with an ileal fistula: A case report

2018 ◽  
Vol 52 ◽  
pp. 120-124 ◽  
Author(s):  
Junko Mukohyama ◽  
Yasuo Sumi ◽  
Kiyonori Kanemitsu ◽  
Hiroshi Hasegawa ◽  
Masashi Yamamoto ◽  
...  
Keyword(s):  
Case Report ◽  
Ileocecal Resection ◽  
Appendiceal Cancer ◽  
Laparoscopic Ileocecal Resection

Systemic therapy for appendiceal cancer

2015 ◽  
pp. 293-304
Author(s):  
Jennifer L. Zadlo ◽  
Cathy Eng
Keyword(s):  
Systemic Therapy ◽  
Appendiceal Cancer

Appendix cancer mimicking ovarian cancer

2002 ◽  
Vol 12 (6) ◽  
pp. 768-772 ◽  
Author(s):  
P. A. Gehrig ◽  
J. F. Boggess ◽  
D. W. Ollila ◽  
P. A. Groben ◽  
L. Van Le
Keyword(s):  
Ovarian Cancer ◽  
Abdominal Mass ◽  
Correct Diagnosis ◽  
Disease Process ◽  
Advanced Ovarian Cancer ◽  
Stage Iv ◽  
Treatment Modalities ◽  
Primary Adenocarcinoma ◽  
Appendiceal Cancer ◽  
Tumor Debulking

Appendiceal adenocarcinoma is a rare malignancy for which there is no characteristic clinical presentation. We describe five women who presented with signs and symptoms characteristic of advanced ovarian cancer but whose final diagnosis was stage IV appendiceal cancer. Between 1998 and 1999, five women treated for presumed ovarian cancer were identified as having primary appendiceal cancer. Medical records and pathology were retrospectively reviewed. The median age was 47 years (range 36–61 years). All had elevated preoperative CA125 levels with a median value of 171 μ/ml (range 46–383). Four women underwent right hemicolectomy with two requiring radical surgical tumor debulking to render them optimally debulked. Four had postoperative chemotherapy, the most common agent used was 5-flourouracil. Median survival was 6.75 months (range 19 days-11 months). Primary adenocarcinoma of the appendix is rare; therefore, the clinical utility of radical tumor debulking and chemotherapy is not well described. Given the poor survival in our series, all efforts should be considered palliative. Although this disease process is uncommon, it should be entertained by gynecologic oncologists in the differential diagnosis of an intra-abdominal mass and ascites. The ability to make the correct diagnosis and differentiate between an ovarian and appendiceal primary is critical as the treatment modalities vary.

scholarly journals Peritoneal Metastases from Appendiceal Cancer

2018 ◽  
Vol 27 (3) ◽  
pp. 551-561 ◽  
Author(s):  
Konstantinos I. Votanopoulos ◽  
Perry Shen ◽  
Aleksander Skardal ◽  
Edward A. Levine
Keyword(s):  
Peritoneal Metastases ◽  
Appendiceal Cancer

Elevated risk of subsequent malignancies in patients with appendiceal cancer: A population-based analysis

2016 ◽  
Vol 35 (5) ◽  
pp. 354-360 ◽  
Author(s):  
Adil Ayub ◽  
Om Parkash ◽  
Norberto Santana-Rodríguez ◽  
Wissam Raad ◽  
Faiz Y. Bhora
Keyword(s):  
Population Based ◽  
Elevated Risk ◽  
Appendiceal Cancer

Peritoneal dissemination of non-carcinoid primary appendiceal cancer

2007 ◽  
Vol 107 (3) ◽  
pp. 592 ◽  
Author(s):  
Laura A. Lambert ◽  
Paul F. Mansfield
Keyword(s):  
Peritoneal Dissemination ◽  
Appendiceal Cancer

Outcomes of neoadjuvant chemotherapy before CRS‐HIPEC for patients with appendiceal cancer

2020 ◽  
Vol 122 (3) ◽  
pp. 388-398
Author(s):  
JC Chen ◽  
Eliza W. Beal ◽  
John Hays ◽  
Timothy M. Pawlik ◽  
Sherif Abdel‐Misih ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Appendiceal Cancer
Sign in / Sign up

Export Citation Format

Share Document